|
Prize Recipients
 |
2012 Prize Co-Recipient: Zhen-Yi Wang, M.D. Professor at the Medical School of the Shanghai Jiao Tong University and Honorary Director of the Shanghai Institute of Haematology
|
 |
2012 Prize Co-Recipient: Zhu Chen, M.D., Ph.D. Minister of Health for the People's Republic of China and Professor at the School of Medicine of the Shanghai Jiao Tong University
|
 |
2011 Prize Recipient: Beatrice Mintz, Ph.D. Professor and Jack Schultz Chair in Basic Science, Fox Chase Cancer Center
|
 |
2010 Prize Recipient: Peter K. Vogt, Ph.D. Professor in the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California |
 |
2009 Prize Recipient: Ronald A. DePinho, M.D. President of The University of Texas MD Anderson Cancer Center and Professor and Director, Belter Institute Department of Medicine and Genetics Dana-Farber Cancer Institute and Harvard Medical School
|
 |
2008 Prize Recipient: Carlo M. Croce, M.D. Director of the Human Cancer Genetics Program and Director of the Institute of Genetics at The Ohio State University
|
 |
2007 Prize Recipient: Webster K. Cavenee, Ph.D. Director of the Ludwig Institute for Cancer Research, San Diego Branch and Distinguished Professor at the University of California, San Diego
|
 |
2006 Prize Recipient: Harold F. Dvorak, M.D. Mallinckrodt Professor Emeritus of Pathology at Harvard Medical School and Chief of the Department of Pathology at Beth Israel Deaconess Medical Center
|

|
Call for Nominations

NFCR is calling for nominations for the 8th Szent-Györgyi Prize for Progress in Cancer Research. To download 2013 Call for Nominations, click here.
2012 Prize Winners

Dr. Zhen-Yi Wang, M.D., Professor at the Medical School of Shanghai Jiao Tong University, and Zhu Chen, M.D., Ph.D., Minister of Health for the Peoples Republic of China and Professor at the School of Medicine of the Shanghai Jiao Tong University, jointly won the 7th Szent-Györgyi Prize for their innovative research that led to the successful development of a new therapeutic approach to acute promyelocytic leukemia (APL). Click here to learn more.
2012 Sponsors:
|